Collectively, our findings suggest that the increased expression of TRIM26 hinders the development of cells by disrupting ETK, leading to the deactivation of AKT/mTOR signaling in ccRCC. This evidence concerns the gene MTOR and nonpapillary renal cell carcinoma.